Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $7.5300 (-2.4%) ($7.5300 - $7.5300) on Wed. Jul. 7, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.03% (three month average) | RSI | 52 | Latest Price | $7.5300(-2.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(70%) ARKK(67%) IWO(66%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -2.015% in a week (0% probabilities). VIXM(-49%) VXX(-37%) UUP(-16%) TLT(-8%) IGOV(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.015% (StdDev 4.03%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.07 | 5 Day Moving Average | $7.92(-4.92%) | 10 Day Moving Average | $8.16(-7.72%) | 20 Day Moving Average | $8.07(-6.69%) | To recent high | -17.1% | To recent low | 9.4% | Market Cap | $623m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |